{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:38:04Z","timestamp":1792643884609,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K08DK127244"],"award-info":[{"award-number":["K08DK127244"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006792","name":"Hartwell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL007899"],"award-info":[{"award-number":["T32HL007899"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA014520"],"award-info":[{"award-number":["P30 CA014520"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["S10 OD023526"],"award-info":[{"award-number":["S10 OD023526"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016452","name":"Department of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin-Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The GATA gene family encodes highly conserved zinc-finger transcription factors that facilitate the development and function of multiple organ systems including the uterus. In the endometrium, GATA2 functions in a positive autoregulatory loop with the progesterone receptor (PGR) and colocalizes with PGR on chromatin to promote PGR transcriptional programs. GATA2 also has PGR-independent functions that maintain endometrial cell identity, and <jats:italic>GATA2<\/jats:italic> transcripts reportedly are down-regulated in endometrial disorders including endometriosis. This event is accompanied by a reciprocal increase in <jats:italic>GATA6<\/jats:italic>. Here, we applied custom anti-GATA2 monoclonal antibodies and performed GATA2 immunohistochemistry (IHC) on patient endometrial tissues corresponding to proliferative, secretory, inactive, and hormone-treated endometrium, as well as endometriosis and endometrial atypical hyperplasia\/endometrioid intraepithelial neoplasia (EAH\/EIN). We also performed IHC for the estrogen receptor, PGR, and GATA6 in relevant groups. The results reveal a tight correlation between GATA2 and PGR expression in the glandular and stromal cells of benign endometrium. GATA2 expression is markedly reduced in stromal but not glandular cells in endometriosis and EAH\/EIN. This reduction in GATA2 expression does not lead to a detectable increase in GATA6 expression in endometriosis. Although average glandular GATA2 expression was preserved in endometriosis and EAH\/EIN cases, its expression was decoupled from PGR, implying that alternative pathways regulate GATA2 levels in these disorders. Our findings indicate that GATA2 dysregulation is a feature of endometriosis and EAH\/EIN, and support a model whereby loss of stromal GATA2 in these disorders contributes to their progesterone insensitivity.<\/jats:p>","DOI":"10.1007\/s43032-024-01730-5","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T21:02:19Z","timestamp":1729717339000},"page":"3880-3891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immunohistochemical Analysis of GATA2 Expression in Endometrium and its Relationship with Hormone Receptor Expression in Benign and Premalignant Endometrial Disorders"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8975-4233","authenticated-orcid":false,"given":"Aysenur","family":"Keske","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3174-6775","authenticated-orcid":false,"given":"Usha S.","family":"Polaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1430-3128","authenticated-orcid":false,"given":"Daniel R.","family":"Matson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"1730_CR1","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1152\/physrev.00031.2019","volume":"100","author":"HOD Critchley","year":"2020","unstructured":"Critchley HOD, Maybin JA, Armstrong GM, Williams ARW. Physiology of the endometrium and regulation of menstruation. Physiol Rev. 2020;100:1149\u201379. https:\/\/doi.org\/10.1152\/physrev.00031.2019.","journal-title":"Physiol Rev"},{"key":"1730_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-3-319-15856-3_10","volume":"216","author":"R-W Su","year":"2015","unstructured":"Su R-W, Fazleabas AT. Implantation and establishment of pregnancy in human and nonhuman primates. Adv Anat Embryol Cell Biol. 2015;216:189\u2013213. https:\/\/doi.org\/10.1007\/978-3-319-15856-3_10.","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"1730_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/s0303-7207(01)00655-4","volume":"186","author":"AT Fazleabas","year":"2002","unstructured":"Fazleabas AT, Strakova Z. Endometrial function: cell specific changes in the uterine environment. Mol Cell Endocrinol. 2002;186:143\u20137. https:\/\/doi.org\/10.1016\/s0303-7207(01)00655-4.","journal-title":"Mol Cell Endocrinol"},{"key":"1730_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.5114\/pm.2015.52154","volume":"14","author":"M Bi\u0144kowska","year":"2015","unstructured":"Bi\u0144kowska M, Woro\u0144 J. Progestogens in menopausal hormone therapy. Prz Menopauzalny. 2015;14:134\u201343. https:\/\/doi.org\/10.5114\/pm.2015.52154.","journal-title":"Prz Menopauzalny"},{"key":"1730_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/0974-2727.66699","volume":"2","author":"N Agarwal","year":"2010","unstructured":"Agarwal N, Subramanian A. Endometriosis \u2013 morphology, clinical presentations and molecular pathology. J Lab Physicians. 2010;2:1\u20139. https:\/\/doi.org\/10.4103\/0974-2727.66699.","journal-title":"J Lab Physicians"},{"key":"1730_CR6","doi-asserted-by":"publisher","first-page":"205031211984824","DOI":"10.1177\/2050312119848247","volume":"7","author":"NP Nijkang","year":"2019","unstructured":"Nijkang NP, Anderson L, Markham R, Manconi F. Endometrial polyps: Pathogenesis, sequelae and treatment. SAGE Open Med. 2019;7:2050312119848247. https:\/\/doi.org\/10.1177\/2050312119848247.","journal-title":"SAGE Open Med"},{"key":"1730_CR7","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/AOG.0000000000004989","volume":"140","author":"KL Ring","year":"2022","unstructured":"Ring KL, Mills AM, Modesitt SC. Endometrial hyperplasia. Obstet Gynecol. 2022;140:1061\u201375. https:\/\/doi.org\/10.1097\/AOG.0000000000004989.","journal-title":"Obstet Gynecol"},{"key":"1730_CR8","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2016.2","volume":"18","author":"MHFM Lentjes","year":"2016","unstructured":"Lentjes MHFM, Niessen HEC, Akiyama Y, de Bru\u00efne AP, Melotte V, van Engeland M. The emerging role of GATA transcription factors in development and disease. Expert Rev Mol Med. 2016;18: e3. https:\/\/doi.org\/10.1017\/erm.2016.2.","journal-title":"Expert Rev Mol Med"},{"key":"1730_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/iub.2204","volume":"72","author":"G Leubolt","year":"2020","unstructured":"Leubolt G, Redondo Monte E, Greif PA. GATA2 mutations in myeloid malignancies: Two zinc fingers in many pies. IUBMB Life. 2020;72:151\u20138. https:\/\/doi.org\/10.1002\/iub.2204.","journal-title":"IUBMB Life"},{"key":"1730_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/371221a0","volume":"371","author":"F-Y Tsai","year":"1994","unstructured":"Tsai F-Y, Keller G, Kuo FC, Weiss M, Chen J, Rosenblatt M, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 1994;371:221\u20136. https:\/\/doi.org\/10.1038\/371221a0.","journal-title":"Nature"},{"key":"1730_CR11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3324\/haematol.2015.137711","volume":"101","author":"M Novakova","year":"2016","unstructured":"Novakova M, Aliova M, Sukova M, Wlodarski M, Janda A, Fro\u0148kov\u00e1 E, et al. Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome. Haematologica. 2016;101:707\u201316. https:\/\/doi.org\/10.3324\/haematol.2015.137711.","journal-title":"Haematologica"},{"key":"1730_CR12","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","volume":"127","author":"MW Wlodarski","year":"2016","unstructured":"Wlodarski MW, Hirabayashi S, Pastor V, Star\u00fd J, Hasle H, Masetti R, et al. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood. 2016;127:1387\u201397. https:\/\/doi.org\/10.1182\/blood-2015-09-669937.","journal-title":"Blood"},{"key":"1730_CR13","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/ng.913","volume":"43","author":"CN Hahn","year":"2011","unstructured":"Hahn CN, Chong C-E, Carmichael CL, Wilkins EJ, Brautigan PJ, Li X-C, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43:1012\u20137. https:\/\/doi.org\/10.1038\/ng.913.","journal-title":"Nat Genet"},{"key":"1730_CR14","doi-asserted-by":"publisher","first-page":"027","DOI":"10.1055\/s-0029-1242990","volume":"28","author":"C Rubel","year":"2010","unstructured":"Rubel C, Jeong J-W, Tsai S, Lydon J, DeMayo F. Epithelial-stromal interaction and progesterone receptors in the mouse uterus. Semin Reprod Med. 2010;28:027\u201335. https:\/\/doi.org\/10.1055\/s-0029-1242990.","journal-title":"Semin Reprod Med"},{"key":"1730_CR15","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.gep.2012.03.004","volume":"12","author":"CA Rubel","year":"2012","unstructured":"Rubel CA, Franco HL, Jeong J-W, Lydon JP, DeMayo FJ. GATA2 is expressed at critical times in the mouse uterus during pregnancy. Gene Expr Patterns. 2012;12:196\u2013203. https:\/\/doi.org\/10.1016\/j.gep.2012.03.004.","journal-title":"Gene Expr Patterns"},{"key":"1730_CR16","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.celrep.2016.09.093","volume":"17","author":"CA Rubel","year":"2016","unstructured":"Rubel CA, Wu S-P, Lin L, Wang T, Lanz RB, Li X, et al. A Gata2-dependent transcription network regulates uterine progesterone responsiveness and endometrial function. Cell Rep. 2016;17:1414\u201325. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.093.","journal-title":"Cell Rep"},{"key":"1730_CR17","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/onc.2017.397","volume":"37","author":"SH Song","year":"2018","unstructured":"Song SH, Jeon MS, Nam JW, Kang JK, Lee YJ, Kang JY, et al. Aberrant GATA2 epigenetic dysregulation induces a GATA2\/GATA6 switch in human gastric cancer. Oncogene. 2018;37:993\u20131004. https:\/\/doi.org\/10.1038\/onc.2017.397.","journal-title":"Oncogene"},{"key":"1730_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.xfss.2023.11.003","volume":"5","author":"ZJ Pavlovic","year":"2024","unstructured":"Pavlovic ZJ, Hsin-Yu Pai A, Hsiao T-T, Yen C-F, Alhasan H, Ozmen A, et al. Dysregulated expression of GATA2 and GATA6 transcription factors in adenomyosis: implications for impaired endometrial receptivity. F S Sci. 2024;5:92\u2013103. https:\/\/doi.org\/10.1016\/j.xfss.2023.11.003.","journal-title":"F S Sci"},{"key":"1730_CR19","doi-asserted-by":"publisher","first-page":"31087","DOI":"10.1074\/jbc.R110.159079","volume":"285","author":"EH Bresnick","year":"2010","unstructured":"Bresnick EH, Lee H-Y, Fujiwara T, Johnson KD, Keles S. GATA switches as developmental drivers. J Biol Chem. 2010;285:31087\u201393. https:\/\/doi.org\/10.1074\/jbc.R110.159079.","journal-title":"J Biol Chem"},{"issue":"1","key":"1730_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1182\/bloodadvances.2023011554","volume":"8","author":"DJ Robbins","year":"2023","unstructured":"Robbins DJ, Pavletich TS, Patil AT, Pahopos DC, Lasarev M, Polaki US, et al. Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia. Blood Adv. 2023;8(1):80\u201392. https:\/\/doi.org\/10.1182\/bloodadvances.2023011554.","journal-title":"Blood Adv"},{"key":"1730_CR21","doi-asserted-by":"publisher","first-page":"e1004158","DOI":"10.1371\/journal.pgen.1004158","volume":"10","author":"MT Dyson","year":"2014","unstructured":"Dyson MT, Roqueiro D, Monsivais D, Ercan CM, Pavone ME, Brooks DC, et al. Genome-wide DNA methylation analysis predicts an epigenetic switch for GATA factor expression in endometriosis. PLoS Genet. 2014;10:e1004158. https:\/\/doi.org\/10.1371\/journal.pgen.1004158.","journal-title":"PLoS Genet"},{"key":"1730_CR22","doi-asserted-by":"publisher","unstructured":"Rajagopalan A, Feng Y, Gayatri MB, Ranheim EA, Klungness T, Matson DR, et al. A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice. J Clin Invest 2023;133(24). https:\/\/doi.org\/10.1172\/JCI173116.","DOI":"10.1172\/JCI173116"},{"key":"1730_CR23","doi-asserted-by":"publisher","unstructured":"Oul\u00e8s B, Rognoni E, Hoste E, Goss G, Fiehler R, Natsuga K, et al. Mutant Lef1 controls Gata6 in sebaceous gland development and cancer. EMBO J 2019;38:e100526. https:\/\/doi.org\/10.15252\/embj.2018100526.","DOI":"10.15252\/embj.2018100526"},{"key":"1730_CR24","doi-asserted-by":"publisher","first-page":"100101","DOI":"10.1016\/j.modpat.2023.100101","volume":"36","author":"B Oul\u00e8s","year":"2023","unstructured":"Oul\u00e8s B, Deschamps L, Sohier P, Tihy M, Chassac A, Couvelard A, et al. Diagnostic accuracy of GATA6 immunostaining in sebaceous tumors of the skin. Mod Pathol. 2023;36:100101. https:\/\/doi.org\/10.1016\/j.modpat.2023.100101.","journal-title":"Mod Pathol"},{"key":"1730_CR25","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/s12276-023-01090-1","volume":"55","author":"H Machino","year":"2023","unstructured":"Machino H, Dozen A, Konaka M, Komatsu M, Nakamura K, Ikawa N, et al. Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas. Exp Mol Med. 2023;55:2205\u201319. https:\/\/doi.org\/10.1038\/s12276-023-01090-1.","journal-title":"Exp Mol Med"},{"key":"1730_CR26","unstructured":"Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumours of female reproductive organs. 2014."},{"key":"1730_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ygyno.2008.06.014","volume":"111","author":"A \u00d8rbo","year":"2008","unstructured":"\u00d8rbo A, Arnes M, Hancke C, Vereide AB, Pettersen I, Larsen K. Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only. Gynecol Oncol. 2008;111:68\u201373. https:\/\/doi.org\/10.1016\/j.ygyno.2008.06.014.","journal-title":"Gynecol Oncol"},{"key":"1730_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ygyno.2004.06.045","volume":"95","author":"PT Ramirez","year":"2004","unstructured":"Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol. 2004;95:133\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2004.06.045.","journal-title":"Gynecol Oncol"},{"key":"1730_CR29","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/s0029-7844(97)00297-4","volume":"90","author":"TC Randall","year":"1997","unstructured":"Randall TC, Kurman RJ. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol. 1997;90:434\u201340. https:\/\/doi.org\/10.1016\/s0029-7844(97)00297-4.","journal-title":"Obstet Gynecol"},{"key":"1730_CR30","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","volume":"25","author":"K Ushijima","year":"2007","unstructured":"Ushijima K, Yahata H, Yoshikawa H, Konishi I, Yasugi T, Saito T, et al. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol. 2007;25:2798\u2013803. https:\/\/doi.org\/10.1200\/JCO.2006.08.8344.","journal-title":"J Clin Oncol"},{"key":"1730_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/sj.bjc.6604102","volume":"98","author":"JV Lacey","year":"2008","unstructured":"Lacey JV, Ioffe OB, Ronnett BM, Rush BB, Richesson DA, Chatterjee N, et al. Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan. Br J Cancer. 2008;98:45\u201353. https:\/\/doi.org\/10.1038\/sj.bjc.6604102.","journal-title":"Br J Cancer"},{"key":"1730_CR32","doi-asserted-by":"publisher","unstructured":"Management of endometrial intraepithelial neoplasia or atypical endometrial hyperplasia: ACOG clinical consensus no. 5. Obstet Gynecol 2023;142:735. https:\/\/doi.org\/10.1097\/AOG.0000000000005297.","DOI":"10.1097\/AOG.0000000000005297"},{"key":"1730_CR33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrendo.2013.255","volume":"10","author":"P Vercellini","year":"2014","unstructured":"Vercellini P, Vigan\u00f2 P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10:261\u201375. https:\/\/doi.org\/10.1038\/nrendo.2013.255.","journal-title":"Nat Rev Endocrinol"},{"key":"1730_CR34","doi-asserted-by":"publisher","first-page":"10554","DOI":"10.3390\/ijms221910554","volume":"22","author":"B Smolarz","year":"2021","unstructured":"Smolarz B, Szy\u0142\u0142o K, Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (Review of literature). Int J Mol Sci. 2021;22:10554. https:\/\/doi.org\/10.3390\/ijms221910554.","journal-title":"Int J Mol Sci"},{"key":"1730_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejogrb.2016.04.021","volume":"209","author":"F Parazzini","year":"2017","unstructured":"Parazzini F, Esposito G, Tozzi L, Noli S, Bianchi S. Epidemiology of endometriosis and its comorbidities. Eur J Obstet Gynecol Reprod Biol. 2017;209:3\u20137. https:\/\/doi.org\/10.1016\/j.ejogrb.2016.04.021.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1730_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bpobgyn.2018.06.001","volume":"51","author":"AL Shafrir","year":"2018","unstructured":"Shafrir AL, Farland LV, Shah DK, Harris HR, Kvaskoff M, Zondervan K, et al. Risk for and consequences of endometriosis: A critical epidemiologic review. Best Pract Res Clin Obstet Gynaecol. 2018;51:1\u201315. https:\/\/doi.org\/10.1016\/j.bpobgyn.2018.06.001.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1730_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.22074\/cellj.2016.3894","volume":"19","author":"M Taghizadeh","year":"2017","unstructured":"Taghizadeh M, Noruzinia M. Lovastatin reduces stemness via epigenetic reprograming of BMP2 and GATA2 in human endometrium and endometriosis. Cell J. 2017;19:50\u201364. https:\/\/doi.org\/10.22074\/cellj.2016.3894.","journal-title":"Cell J"},{"key":"1730_CR38","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1038\/s41467-023-39008-0","volume":"14","author":"SC Yang","year":"2023","unstructured":"Yang SC, Park M, Hong K-H, La H, Park C, Wang P, et al. CFP1 governs uterine epigenetic landscapes to intervene in progesterone responses for uterine physiology and suppression of endometriosis. Nat Commun. 2023;14:3220. https:\/\/doi.org\/10.1038\/s41467-023-39008-0.","journal-title":"Nat Commun"},{"key":"1730_CR39","doi-asserted-by":"publisher","first-page":"e13078","DOI":"10.1111\/aji.13078","volume":"81","author":"M Izawa","year":"2019","unstructured":"Izawa M, Taniguchi F, Harada T. GATA6 expression promoted by an active enhancer may become a molecular marker in endometriosis lesions. Am J Reprod Immunol. 2019;81:e13078. https:\/\/doi.org\/10.1111\/aji.13078.","journal-title":"Am J Reprod Immunol"},{"key":"1730_CR40","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1016\/j.fertnstert.2010.01.038","volume":"93","author":"J Lee","year":"2010","unstructured":"Lee J, Banu SK, Rodriguez R, Starzinski-Powitz A, Arosh JA. Selective blockade of prostaglandin E2 receptors EP2 and EP4 signaling inhibits proliferation of human endometriotic epithelial cells and stromal cells through distinct cell cycle arrest. Fertil Steril. 2010;93:2498\u2013506. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.01.038.","journal-title":"Fertil Steril"},{"key":"1730_CR41","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.mce.2010.11.022","volume":"332","author":"J Lee","year":"2011","unstructured":"Lee J, Banu SK, Subbarao T, Starzinski-Powitz A, Arosh JA. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases. Mol Cell Endocrinol. 2011;332:306\u201313. https:\/\/doi.org\/10.1016\/j.mce.2010.11.022.","journal-title":"Mol Cell Endocrinol"},{"key":"1730_CR42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1182\/bloodadvances.2023011554","volume":"8","author":"DJ Robbins","year":"2024","unstructured":"Robbins DJ, Pavletich TS, Patil AT, Pahopos D, Lasarev M, Polaki US, et al. Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia. Blood Adv. 2024;8:80\u201392. https:\/\/doi.org\/10.1182\/bloodadvances.2023011554.","journal-title":"Blood Adv"},{"key":"1730_CR43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1177\/1933719118756751","volume":"26","author":"LA Bernardi","year":"2019","unstructured":"Bernardi LA, Dyson MT, Tokunaga H, Sison C, Oral M, Robins JC, et al. The essential role of GATA6 in the activation of estrogen synthesis in endometriosis. Reprod Sci. 2019;26:60\u20139. https:\/\/doi.org\/10.1177\/1933719118756751.","journal-title":"Reprod Sci"},{"key":"1730_CR44","doi-asserted-by":"publisher","first-page":"17065","DOI":"10.1073\/pnas.0506164102","volume":"102","author":"H Im","year":"2005","unstructured":"Im H, Grass JA, Johnson KD, Kim S-I, Boyer ME, Imbalzano AN, et al. Chromatin domain activation via GATA-1 utilization of a small subset of dispersed GATA motifs within a broad chromosomal region. Proc Natl Acad Sci U S A. 2005;102:17065\u201370. https:\/\/doi.org\/10.1073\/pnas.0506164102.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-024-01730-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-024-01730-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-024-01730-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T16:09:57Z","timestamp":1733155797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-024-01730-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1730"],"URL":"https:\/\/doi.org\/10.1007\/s43032-024-01730-5","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}